Idexx Laboratories Inc vs. Insight Molecular Diagnostics Inc. Common Stock
IDXX
Idexx Laboratories Inc
$518.39 +0.12%
VS IMDXInsight Molecular Diagnostics Inc. Common Stock
$3.44 -0.86%
Idexx Laboratories Inc and Insight Molecular Diagnostics Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| IDXX | IMDX | |
|---|---|---|
| Market Cap | $40.84 billion | $113.55 million |
| Revenue (TTM) | $4.55 billion | — |
| Net Income (TTM) | $1.14 billion | — |
IDXX leads on 1 of 1 size & scale factors.
Valuation
| IDXX | IMDX | |
|---|---|---|
| P/E Ratio | 36.43 | — |
| Price / Book | 25.33 | — |
| Price / Sales | 8.97 | — |
IDXX and IMDX split the valuation factors evenly.
Profitability
| IDXX | IMDX | |
|---|---|---|
| Net Margin | 25.03% | — |
| Return on Equity | 70.67% | — |
IDXX and IMDX split the profitability factors evenly.
Risk & Sentiment
| IDXX | IMDX | |
|---|---|---|
| Short Interest | 1.79% | 0.93% |
IMDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: IDXX overview, IDXX financials, IMDX overview, IMDX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.